NT-12

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNT-12
Drug Alias Namerepurposed anti-inflammatory drug combination therapy (Novear)NT-12
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHearing Loss, Noise-Induced
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovear Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesNovear Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsHearing Loss, Noise-Induced
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A